Doctors and scientists write open letter warning about safety concerns of COVID-19 experimental vaccines

The following is an open letter written by a group of doctors and scientists who call themselves Doctors for COVID Ethics. It was addressed to Emer Cooke, Executive Director of the European Medicines Agency (EMA) and was published last February 28, 2021 and circulated March 10, 2021.

The authors are requesting the EMA to provide responses to seven issues relating to the vaccines, including proof that there was an actual emergency when the EMA granted the vaccines approval for conditional use in humans.

Here are the seven issues, as quoted verbatim herein:
(1) Following intramuscular injection, it must be expected that the gene-based vaccines will reach the bloodstream and disseminate throughout the body. We request evidence that this possibility was excluded in pre-clinical animal models with all three vaccines prior to their approval for use in humans by the EMA.
(2) If such evidence is not available, it must be expected that the vaccines will remain entrapped in the circulation and be taken up by endothelial cells. There is reason to assume that this will happen particularly at sites of slow blood flow, i.e. in small vessels and capillaries. We request evidence that this probability was excluded in pre-clinical animal models with all three vaccines prior to their approval for use in humans by the EMA.
(3) If such evidence is not available, it must be expected that during expression of the vaccines’ nucleic acids, peptides derived from the spike protein will be presented via the MHC I — pathway at the luminal surface of the cells. Many healthy individuals have CD8-lymphocytes that recognize such peptides, which may be due to prior COVID infection, but also to cross-reactions with other types of Coronavirus. We must assume that these lymphocytes will mount an attack on the respective cells. We request evidence that this probability was excluded in pre-clinical animal models with all three vaccines prior to their approval for use in humans by the EMA.
(4) If such evidence is not available, it must be expected that endothelial damage with subsequent triggering of blood coagulation via platelet activation will ensue at countless sites throughout the body. We request evidence that this probability was excluded in pre-clinical animal models with all three vaccines prior to their approval for use in humans by the EMA.
(5) If such evidence is not available, it must be expected that this will lead to a drop in platelet counts, appearance of D-dimers in the blood, and to myriad ischaemic lesions throughout the body including in the brain, spinal cord and heart. Bleeding disorders might occur in the wake of this novel type of DIC-syndrome including, amongst other possibilities, profuse bleedings and haemorrhagic stroke. We request evidence that all these possibilities were excluded in pre-clinical animal models with all three vaccines prior to their approval for use in humans by the EMA.
(6) The SARS-CoV-2 spike protein binds to the ACE2 receptor on platelets, which results in their activation. Thrombocytopenia has been reported in severe cases of SARS-CoV-2 infection. Thrombocytopenia has also been reported in vaccinated individuals. We request evidence that the potential danger of platelet activation that would also lead to disseminated intravascular coagulation (DIC) was excluded with all three vaccines prior to their approval for use in humans by the EMA.
(7)The sweeping across the globe of SARS-CoV-2 created a pandemic of illness associated with many deaths. However, by the time of consideration for approval of the vaccines, the health systems of most countries were no longer under imminent threat of being overwhelmed because a growing proportion of the world had already been infected and the worst of the pandemic had already abated. Consequently, we demand conclusive evidence that an actual emergency existed at the time of the EMA granting Conditional Marketing Authorisation to the manufacturers of all three vaccines, to justify their approval for use in humans by the EMA, purportedly because of such an emergency.

Additionally, the authors “demand that the approval for use of the gene-based vaccines be withdrawn until all the above issues [raised] have been addressed by the exercise of due diligence by the EMA.

Some of the notable original signatories of the letter include Dr. Michael Yeadon, Prof. Sucharit Bhakdi, Dr. Marco Chiesa, Dr. C Stephen Frost, and several other doctors and scientists from Germany, Cananda, Austria. To date, the letter has been signed by over 80 doctors and scientists.

Editor’s Note: Despite the huge number of doctors supporting the open letter, the EMA has not provided its responses raised by the authors. Moreover, the letter has been greatly censored, both in social media and search engines.

This open letter shows us that the question of vaccine safety has not been fully resolved, and authorities have not provided legitimate scientists adequate proof of objective and unbiased decision making. If media is silent about the opposition to mass vaccination, it is not because there is no opposition. It is because these opposing groups are systematically censored and deplatformed.

Absence of response, especially on question number seven (7) will make EMA open to be legally charged for crimes against humanity.